insights_auto
Why is EDIT down 4,09%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
1,64 US$
arrow_downward
-4,09%(-0,070) 1D
1,66 US$
arrow_upward
+1,22% (+0,020)bedtimeAfter hours
Closed: 20 ნოე, 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
1,69 US$
High
1,78 US$
Low
1,63 US$
Mkt. cap
253,12 მლნ.
Avg. vol.
2,24 მლნ.
Volume
2,68 მლნ.
52-wk high
3,94 US$
52-wk low
1,63 US$
EPS
-0,62 US$
Beta
2,09
Shares outstanding
154,34 მლნ.
No. of employees
87
Open
1,69 US$
High
1,78 US$
Low
1,63 US$
Mkt. cap
253,12 მლნ.
Avg. vol.
2,24 მლნ.
Volume
2,68 მლნ.
52-wk high
3,94 US$
52-wk low
1,63 US$
EPS
-0,62 US$
Beta
2,09
Shares outstanding
154,34 მლნ.
No. of employees
87
News stories
From web sources and news partners
FOREX.com
·
1 საათის წინ
S&P 500, Nasdaq 100 Drive into Correction Territory
TradingView
·
2 საათის წინ
Ed Yardeni Says Investors Are Overreacting to S&P 500 Selloff
Nacionale
·
8 საათის წინ
Is the S&P 500 in a bear market, and will it rally? No, it's in a correction, 11.6% below its record
cwibc.co.id
·
11 წუთის წინ
Wall Street Sell-Off Pushes S&P 500 and Dow Into Correction
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc